FDA Inspection
Biomat USA, Inc.Biomat USA, Inc. – FDA Inspection, Nov 20, 2015
Record Details
This FDA Inspection record concerns Biomat USA, Inc., with an inspection on November 20, 2015, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Company
- Biomat USA, Inc.
- Inspection Date
- November 20, 2015
- Product Type
- Biologics
View Company Profile
ID · f03f6557-97a2-4d11-a42f-dbb569a25657
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 971470
- FDA center
- Biologics
- Project area
- Blood and Blood Products
FDA Citations
1- 21 CFR 606.40(a)(1)Provide space for examination
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Biomat USA, Inc.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| June 26, 2025 | Not classified | Baltimore District Office | |
| January 11, 2018 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| August 29, 2014 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| May 12, 2012 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| January 14, 2010 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
Other documents for Biomat USA, Inc.
- FDA Inspection 1277477 - 2025-06-26
- FDA Inspection 1040706 - 2018-01-11
- FDA Inspection 894264 - 2014-08-29
- FDA Inspection 783814 - 2012-05-12
- FDA Inspection 649309 - 2010-01-14
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.